| Item Type | Name |
|
Academic Article
|
Complex regulation of CDK2 during phorbol ester-induced hematopoietic differentiation.
|
|
Academic Article
|
Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells.
|
|
Academic Article
|
Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc.
|
|
Academic Article
|
Regulation of the p58GTA cell division control-related protein kinase during phorbol 12-myristate 13-acetate-induced terminal differentiation of U937 cells.
|
|
Academic Article
|
Regulation of myeloid cell growth by distinct effectors of Ras.
|
|
Academic Article
|
A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group study.
|
|
Academic Article
|
Treatment of patients with metastatic melanoma with bryostatin-1--a phase II study.
|
|
Academic Article
|
Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells.
|
|
Academic Article
|
AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex.
|
|
Academic Article
|
Regulation of RUNX1/AML1 during the G2/M transition.
|
|
Academic Article
|
Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma.
|
|
Academic Article
|
Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer.
|
|
Academic Article
|
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.
|
|
Academic Article
|
Inhibition of leukemic cell growth by the protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2.
|
|
Academic Article
|
Mapping the intracytoplasmic regions of the alpha granulocyte-macrophage colony-stimulating factor receptor necessary for cell growth regulation.
|
|
Academic Article
|
A critical role for the cytoplasmic domain of the granulocyte-macrophage colony-stimulating factor alpha receptor in mediating cell growth.
|
|
Academic Article
|
Inhibitors of cyclin-dependent kinase and cancer.
|
|
Academic Article
|
A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas.
|
|
Academic Article
|
Role of thoracic radiotherapy combined with chemotherapy in limited stage small cell lung cancer (SCLC). A randomized multicenter phase III trial.
|
|
Academic Article
|
Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial.
|
|
Academic Article
|
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas.
|
|
Academic Article
|
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
|
|
Academic Article
|
Differentiation and growth modulation of chronic myelogenous leukemia cells by bryostatin.
|
|
Academic Article
|
A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma.
|
|
Academic Article
|
Regulation of Skp2 levels by the Pim-1 protein kinase.
|
|
Academic Article
|
Interleukin-3 and bryostatin 1 mediate rapid nuclear envelope protein phosphorylation in growth factor-dependent FDC-P1 hematopoietic cells. A possible role for nuclear protein kinase C.
|
|
Academic Article
|
A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.
|
|
Academic Article
|
Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
|
|
Academic Article
|
The cytoplasmic domain of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha subunit is essential for both GM-CSF-mediated growth and differentiation.
|
|
Concept
|
S Phase
|
|
Concept
|
Cell Division
|
|
Concept
|
S-Phase Kinase-Associated Proteins
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
G2 Phase
|
|
Concept
|
G1 Phase
|
|
Academic Article
|
Phase I trial of weekly docetaxel, total androgen blockade, and image-guided intensity-modulated radiotherapy for localized high-risk prostate adenocarcinoma.
|
|
Academic Article
|
Insulin receptor substrate 1 is a substrate of the Pim protein kinases.
|
|
Academic Article
|
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.
|
|
Academic Article
|
Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells.
|
|
Academic Article
|
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
|